Lung cancer may be curable, depending on a number of factors, including your age, health, stage of cancer, and how it ...

By Dr. Priyom Bose, Ph.D. A new AI tool reads lung cancer biopsy slides in under an hour, accurately predicting mutations and ...

Lung cancer can be hereditary, with mutations in the EGFR and KRAS genes potentially playing a role. Smoking, however, is by far the biggest risk factor. How Genetic Mutations Affect Your Lung ...

Nearly a quarter of all newly diagnosed patients with advanced lung cancer are not given a test that could improve their chances for long-term survival and reduce their side effects.

An AI-based EGFR biomarker tool could preclude the need for a rapid PCR test in nearly half of advanced lung adenocarcinoma cases, a study has suggested.

They want to gain a deeper understanding of why the disease behaves differently in these patients. Read more at ...

The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.

The approval of sunvozertinib, an oral irreversible EGFR inhibitor, was supported by data from the WU-KONG1B trial (ClinicalTrials.gov Identifier: NCT03974022 ). The primary efficacy population ...

This week’s edition of The Targeted Pulse spotlights 5 key developments shaping the landscape of targeted oncology.

With ever-growing treatment options, clinical care access and a new focus on integrative strategies, cancer centers are constantly upgrading their services and options for patients. Becker’s asked ...